arrow
M

Morten Orebo Holmström

University of Copenhagen
H指数:20
被引数:1,449

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Immune reconstitution in patients with myelofibrosis conditioned with a non-myeloablative regimen prior to allogeneic stem cell transplantation

非清髓性方案预处理后异基因干细胞移植患者的免疫重建,其中myelofibrosis为骨髓纤维化。

2026-04-080
PRE
Moving for optimal immunity: the effect of acute high-intensity interval training on phenotype; virus specificity and chemokine receptor expression in human CD8+ T cells
2026-01-190
OAAI
Individualized Treosulfan-based conditioning improves outcomes of allogeneic hematopoietic transplantation for myelodysplastic syndrome: A 25-Year retrospective, population-based analysis

基于Treosulfan的个体化预处理可改善骨髓增生异常综合征的同种异基因造血移植结局:一项25年回顾性、基于人群的分析

2025-11-280
OAAI
TGF-β-specific T cells are frequent in peripheral blood and bone-marrow from patients with myeloproliferative neoplasms

TGF-β特异性T细胞在骨髓增生性肿瘤患者的外周血和骨髓中较为常见。

Leukemia
IF13.4
2025-11-100
PRE
Non-myeloablative Allogeneic Hematopoietic Stem Cell Transplantation for Myelofibrosis. A Population-Based Study from Eastern Denmark

非清髓性异基因造血干细胞移植治疗骨髓纤维化。一项来自丹麦东部的基于人群的研究。

2025-06-010
OAAI
Therapeutic cancer vaccination against mutant calreticulin in myeloproliferative neoplasms induces expansion of specific T cells in the periphery but specific T cells fail to enrich in the bone marrow
2023-08-172
OAAI
Case Report: First longitudinal study of a patient with CALR positive clonal hematopoiesis of indeterminate potential developing into pre-fibrotic myelofibrosis

病例报告: 对具有不确定潜能的CALR阳性克隆造血发展为纤维化前骨髓纤维化的患者的首次纵向研究

2023-05-082
OAAI
Pre-existing TGF-β-specific T-cell immunity in patients with pancreatic cancer predicts survival after checkpoint inhibitors combined with radiotherapy

胰腺癌患者预先存在的tgf-β 特异性T细胞免疫可预测检查点抑制剂联合放疗后的生存

2023-03-228
OAAI
First in man study: Bcl-Xl_42-CAF®09b vaccines in patients with locally advanced prostate cancer

人类研究中的第一项: Bcl-Xl_42-CAF®09b疫苗在局部晚期前列腺癌患者中的应用

2023-03-144
OAAI
Anti-PD-L1/PD-L2 therapeutic vaccination in untreated chronic lymphocytic leukemia patients with unmutated IgHV
2022-11-224
OAAI
Patients with myeloproliferative neoplasms harbor high frequencies of CD8 T cell-platelet aggregates associated with T cell suppression (vol 13, 866610, 2022)
2022-08-051
OAAI
Calreticulin mutant myeloproliferative neoplasms induce MHC-I skewing, which can be overcome by an optimized peptide cancer vaccine

钙网蛋白突变体骨髓增生性肿瘤诱导mhc-i偏斜,这可以通过优化的肽癌症疫苗来克服

2022-06-1512
PRE
A phase 1/2 trial of an immune-modulatory vaccine against IDO/PD-L1 in combination with nivolumab in metastatic melanoma (vol 27, pg 2212, 2021)
2022-03-082
OAAI
Peptide vaccination activating Galectin-3-specific T cells offers a novel means to target Galectin-3-expressing cells in the tumor microenvironment
2022-01-2710
OA